Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome
- 1 July 1996
- journal article
- case report
- Published by Wiley in Movement Disorders
- Vol. 11 (4) , 431-433
- https://doi.org/10.1002/mds.870110413
Abstract
We describe a 13‐year‐old boy with Tourette's syndrome (TS) manifested chiefly by severe coprolalia, obsessive compulsive disorder, and attention deficit hyperactivity disorder. He was treated with unilateral injections of botulinum toxin to the vocal cord and experienced marked improvement in coprolalia as well as marked reduction in the premonitory urges associated with the vocal tics and coprolalia. As a result of the improvement, the patient was able to attend school and church and was able to socialize. Botulinum toxin may interfere with a sensory reflex are required to perpetuate tics and coprolalia in TS, possibly by reducing local build‐up of tension or muscle contraction in affected areas.Keywords
This publication has 10 references indexed in Scilit:
- Botulinum toxin in the treatment of dystonic ticsMovement Disorders, 1994
- Coprolalia in younger patients with Gilles de la tourette syndromeMovement Disorders, 1994
- “Signing tics”—insights into the pathophysiology of symptoms in Tourette's syndromeAnnals of Neurology, 1993
- Adult tics in Gilles de la Tourette's syndromeNeurology, 1992
- Therapeutic Uses of Botulinum ToxinNew England Journal of Medicine, 1991
- Patient perception of tics and other movement disordersNeurology, 1991
- Tourette Syndrome and Other Tic Disorders Diagnosis, Pathophysiology, and TreatmentMedicine, 1991
- Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm.Journal of Neurology, Neurosurgery & Psychiatry, 1990
- Sensory tics in Tourette's syndromeNeurology, 1989
- Sensory Experiences of Gilles de la Tourette SyndromeArchives of General Psychiatry, 1980